重复给予钆特酸葡甲胺或钆双胺后大鼠小脑深部核团残留钆的全面形态分析
该研究对大鼠重复给予大环状钆特酸葡甲胺或线性钆双胺,末次注射4个月后取小脑深部核团,采用ICP-MS、尺寸排阻色谱、单颗粒ICP-MS、NanoSIMS和STEM-EDX分析钆形态。钆特酸葡甲胺组总钆0.25 nmol/g,主要为水溶性低分子完整对比剂;钆双胺组总钆24.3 nmol/g,可溶部分以约440 kDa大分子为主,主要残留在不溶性颗粒,为混合钆/钙磷酸盐。
要点
- 钆双胺组小脑深部核团总钆24.3 nmol/g,远高于钆特酸葡甲胺组的0.25 nmol/g。
- 钆特酸葡甲胺组钆主要在水溶性低分子部分,最可能为完整对比剂形式。
- 钆双胺组主要残留为不溶性颗粒,约100-200 nm海胆状无定形结构,钆与钙、氧、磷共定位。
核心结论
- 钆特酸葡甲胺组残留钆主要为完整对比剂的水溶性低分子形式,钆双胺组主要残留为不溶性混合钆/钙磷酸盐颗粒,该形态分析为线性钆对比剂脱螯合及脑内钆沉积机制提供了证据。
研究设计与样本
- 动物实验,三组健康雌性Sprague-Dawley大鼠每组6只,分别重复静脉给予钆特酸葡甲胺、钆双胺或生理盐水,末次注射4个月后处死,每组6只小脑深部核团混合后经水与尿素两步提取,采用ICP-MS、尺寸排阻色谱-ICP-MS、单颗粒ICP-MS、NanoSIMS和STEM-EDX分析。
诊断标准与关键数值
- 钆特酸葡甲胺组小脑深部核团总钆0.25 nmol/g,钆双胺组24.3 nmol/g;钆双胺组水溶性部分含完整钆双胺不足1%,主要可溶形态为约440 kDa大分子,不溶性颗粒约100-200 nm。
局限性
- 钆双胺组尺寸排阻色谱柱回收率不完全,提示可能存在解离钆离子与内源性分子形成的不稳定络合物。
- 可溶部分中约440 kDa大分子之一被推测为钆与铁结合蛋白(铁蛋白)的复合物,但仅为推测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: Several preclinical studies have reported the presence of gadolinium (Gd) in different chemical forms in the brain, depending on the class (macrocyclic versus linear) of Gd-based contrast agent (GBCA) administered. The aim of this study was to identify, with a special focus on insoluble species, the speciation of Gd retained in the deep cerebellar nuclei (DCN) of rats administered repeatedly with gadoterate or gadodiamide 4 months after the last injection.
METHODS: Three groups (N = 6/group) of healthy female Sprague-Dawley rats (SPF/OFA rats; Charles River, L'Arbresle, France) received a cumulated dose of 50 mmol/kg (4 daily intravenous administrations of 2.5 mmol/kg, for 5 weeks, corresponding to 80-fold the usual clinical dose if adjusted for man) of gadoterate meglumine (macrocyclic) or gadodiamide (linear) or isotonic saline for the control group (4 daily intravenous administrations of 5 mL/kg, for 5 weeks). The animals were sacrificed 4 months after the last injection. Deep cerebellar nuclei were dissected and stored at -80°C before sample preparation. To provide enough tissue for sample preparation and further analysis using multiple techniques, DCN from each group of 6 rats were pooled. Gadolinium species were extracted in 2 consecutive steps with water and urea solution. The total Gd concentrations were determined by inductively coupled plasma mass spectrometry (ICP-MS). Soluble Gd species were analyzed by size-exclusion chromatography coupled to ICP-MS. The insoluble Gd species were analyzed by single-particle (SP) ICP-MS, nanoscale secondary ion mass spectroscopy (NanoSIMS), and scanning transmission electron microscopy with energy-dispersive X-ray spectroscopy (STEM-EDX) for elemental detection.
RESULTS: The Gd concentrations in pooled DCN from animals treated with gadoterate or gadodiamide were 0.25 and 24.3 nmol/g, respectively. For gadoterate, the highest amount of Gd was found in the water-soluble fractions. It was present exclusively as low-molecular-weight compounds, most likely as the intact GBCA form. In the case of gadodiamide, the water-soluble fraction of DCN was composed of high-molecular-weight Gd species of approximately 440 kDa and contained only a tiny amount (less than 1%) of intact gadodiamide. Furthermore, the column recovery calculated for this fraction was incomplete, which suggested presence of labile complexes of dissociated Gd3+ with endogenous molecules. The highest amount of Gd was detected in the insoluble residue, which was demonstrated, by SP-ICP-MS, to be a particulate form of Gd. Two imaging techniques (NanoSIMS and STEM-EDX) allowed further characterization of these insoluble Gd species. Amorphous, spheroid structures of approximately 100-200 nm of sea urchin-like shape were detected. Furthermore, Gd was consistently colocalized with calcium, oxygen, and phosphorous, strongly suggesting the presence of structures composed of mixed Gd/Ca phosphates. No or occasional colocalization with iron and sulfur was observed.
CONCLUSION: A dedicated analytical workflow produced original data on the speciation of Gd in DCN of rats repeatedly injected with GBCAs. The addition, in comparison with previous studies of Gd speciation in brain, of SP element detection and imaging techniques allowed a comprehensive speciation analysis approach. Whereas for gadoterate the main fraction of retained Gd was present as intact GBCA form in the soluble fractions, for linear gadodiamide, less than 10% of Gd could be solubilized and characterized using size-exclusion chromatography coupled to ICP-MS. The main Gd species detected in the soluble fractions were macromolecules of 440 kDa. One of them was speculated to be a Gd complex with iron-binding protein (ferritin). However, the major fraction of residual Gd was present as insoluble particulate species, very likely composed of mixed Gd/Ca phosphates. This comprehensive Gd speciation study provided important evidence for the dechelation of linear GBCAs and offered a deeper insight into the mechanisms of Gd deposition in the brain.
引用
- Strzeminska I, Factor C, Jimenez-Lamana J, et al. Comprehensive Speciation Analysis of Residual Gadolinium in Deep Cerebellar Nuclei in Rats Repeatedly Administered With Gadoterate Meglumine or Gadodiamide. Invest Radiol. 2022. PMID: 35066532. doi:10.1097/RLI.0000000000000846
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。